Media Inquiries: For all MAVA media inquiries, please contact us at 703-506-9300 or email


Check back regularly for news, coverage, and announcements about MAVA.


New Enterprise Associates, Osage University Partners participates in $34.5 Million Round for Mirna Therapeutics

New Enterprise Associates (NEA), the Chevy Chase-based venture capital firm, has taken part in a new $34.5 million round of funding for Texas-based Mirna Therapeutics, a biopharmaceutical firm developing cancer therapeutics. Sofinnova Ventures led the company's third round, which also included participation from Pfizer Ventures, Osage University Partners, Correlation Ventures and several previous investors. Mirna will use the proceeds to advance its lead product candidate through human studies. Ed Mathers, a partner at NEA, will join the company's board of directors.

Read More